ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for discussion 같은 생각을 가진 투자자들과 토론할 수 있는 활발한 포럼에서 상호 작용하려면 등록하세요.

FUSN Fusion Pharmaceuticals Inc

21.44
-0.05 (-0.23%)
04 5월(5) 2024 - 마감
15분 지연
기업명 주식 심볼 시장 주식 타입
Fusion Pharmaceuticals Inc FUSN 나스닥 보통주
  가격 변동 가격 변동 % 주식 가격 최근 거래 시간
-0.05 -0.23% 21.44 09:00:00
개장가 저가 고가 종가 전일 종가
21.50 21.43 21.51 21.45 21.49
시세 정보 더보기 »

최근 뉴스

일자 시간 출처 제목
27/04/202402:56PRNUSKuehn Law Encourages HCP, IP, SLCA, and FUSN Investors to..
26/04/202405:34PRNUSFusion Pharmaceuticals Mails Circular for Special Meeting of..
10/04/202405:05PRNCAFusion Pharmaceuticals Announces Presentation of Interim..
21/03/202405:10PRNUSKuehn Law Encourages DRQ, EVBG, FREE, and FUSN Investors to..
21/03/202405:05PRNCAFusion Pharmaceuticals Reports Fourth Quarter and Full Year..
19/03/202416:00PRNUSFusion Pharmaceuticals to be Acquired by AstraZeneca,..
06/03/202421:45PRNUSFusion Pharmaceuticals Announces Inducement Grants Under..
06/03/202406:43PRNUSFusion Pharmaceuticals to Present Interim Data from the..
26/02/202421:45PRNCAFusion Pharmaceuticals to Present at Upcoming March Investor..
17/02/202406:05EDGAR2Form 8-K - Current report
16/02/202422:45PRNUSFusion Pharmaceuticals Enters into Exclusive Worldwide..
07/02/202421:45PRNUSFusion Pharmaceuticals to Present at the Oppenheimer 34th..
07/02/202406:45PRNUSFusion Pharmaceuticals Announces Inducement Grants Under..
20/01/202406:13EDGAR2Form 8-K - Current report
20/01/202406:10EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
05/01/202422:51EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/01/202422:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/01/202422:46EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/01/202422:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/01/202420:14IHMARKETNEWSWall Street Highlights: Google Rejects Union Negotiations,..
05/01/202408:53DJNShares of Fusion Pharmaceuticals Rise 7.8% With Study..
05/01/202406:31EDGAR2Form 8-K - Current report
05/01/202406:05PRNUSFusion Pharmaceuticals Announces Clinical Program and..
16/11/202320:45BWBWXT Medical Expands Collaboration with Fusion..
09/11/202306:15PRNCAFusion Pharmaceuticals Announces Inducement Grants Under..
08/11/202322:15PRNCAFusion Pharmaceuticals to Present at Upcoming Investor..
07/11/202322:00EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/11/202321:45EDGAR2Form 8-K - Current report
07/11/202321:00PRNCAFusion Pharmaceuticals Announces Third Quarter 2023..
17/10/202305:59EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/10/202305:58EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/10/202305:56EDGAR2Form 3 - Initial statement of beneficial ownership of..
17/10/202305:30EDGAR2Form 8-K - Current report
16/10/202320:50PRNCAFusion Pharmaceuticals Appoints Life Science Industry..
12/10/202320:45PRNUSFusion Pharmaceuticals Announces Presentation of Preclinical..
07/09/202305:25PRNUSFusion Pharmaceuticals Announces Inducement Grants Under..
06/09/202305:10PRNCAFusion Pharmaceuticals to Present at Upcoming September..
10/08/202305:05PRNUSFusion Pharmaceuticals Announces Inducement Grants Under..
08/08/202321:21EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/08/202320:30EDGAR2Form 8-K - Current report
08/08/202320:00PRNUSFusion Pharmaceuticals Announces Second Quarter 2023..
07/07/202305:05PRNUSFusion Pharmaceuticals Announces Inducement Grants Under..
26/06/202321:05PRNCAFusion Pharmaceuticals to Present Interim Data from Phase 1..
16/06/202321:05PRNCAFusion Pharmaceuticals to Present at the TD Cowen..
07/06/202320:35PRNCAFusion Pharmaceuticals Announces Inducement Grants Under..
01/06/202305:10PRNUSFusion Pharmaceuticals to Present at the Jefferies..
11/05/202320:15PRNUSFusion Pharmaceuticals Announces First Quarter 2023..
09/05/202320:45PRNUSFusion Pharmaceuticals to Present at the Guggenheim..

최근 히스토리

Delayed Upgrade Clock